Bevacizumab 400/16ml Cizumab

Trade Name:Cizumab

Manufacturer:Hetero Healthcare Ltd

Presentation: injection


What is the purpose of Bevacizumab 400/16ml injection?

A chemical called Bevacizumab 400/16ml aids the body in the battle against cancer. It stops particular blood vessel types from growing into cancer cells. By depriving the cancer cells of the resources they require to develop, this helps to slow down the growth of cancerous cells.

What is 400 mg of bevacizumab?

Products for injecting bevacizumab are utilised.
Antiangiogenic agents are a class of drugs that includes bevacizumab injectable products. They function by preventing the growth of blood vessels, which supply oxygen and nutrition to tumours. This might inhibit the development and spread of malignancies.

Bevacizumab is chemotherapy, right?

Chemotherapy targets rapidly proliferating cells, such as cancer cells. Chemotherapy functions differently than Avastin® (bevacizumab). When combined with chemotherapy, avastin attacks your cancer from a different aspect. Avastin is an anti-angiogenic (tumor-starving) treatment.

What negative effects does Bevacizumab 400/16ml have?

  • Epistaxis
  • headache
  • hypertension
  • rhinitis
  • proteinuria
  • taste alteration
  • dry skin
  • haemorrhage
  • lacrimation disorder
  • back pain, and exfoliative dermatitis were the most frequent adverse reactions seen in patients receiving Avastin as a a rate of >10% as a single agent or in conjunction with other anti-cancer treatments.

To know more Click here

How is Bevacizumab 400/16ml administered?

Avastin® (bevacizumab) is administered intravenously. This means that you receive Avastin either through a port, a device inserted beneath your skin, or through a tiny needle in your vein. Avastin is administered intravenously, thus infusion-related problems could happen.

Bevacizumab 400/16ml Does it work?

Conclusions: Low-dose bevacizumab has the potential to significantly improve progression-free survival in patients with unresectable NSCLC, whereas high-dose bevacizumab has the potential to improve tumour response rate, prolong progression-free survival, and increase 2-year overall survival rates at the expense of a higher rate of treatment-related death.

Bevacizumab 400/16ml causes bleeding for what reason?

Uncertainty surrounds the mechanism underlying bleeding brought on by bevacizumab. It is most likely connected to the suppression of VEGF signalling. VEGF serves to preserve the integrity of the vascular system by encouraging endothelial cell survival and proliferation.

Is immunotherapy bevacizumab a thing?

Atezolizumab, a monoclonal antibody used in immunotherapy, may aid the body’s immune system in combating the disease and may prevent tumour cells from proliferating and spreading. The drug bevacizumab belongs to a group of drugs known as antiangiogenic agents.

The usage of Bevacizumab 400/16ml in Covid: Why?

Bevacizumab has therapeutic efficacy by enhancing oxygenation and reducing the time spent on oxygen support when compared to comparable controls. According to our research, bevacizumab in addition to normal therapy is quite helpful for patients with severe Covid-19. There is a need for a randomised controlled experiment.

We are a regular distributor, a supplier based in India, and an exporter with operations in more than five foreign countries, including the UAE, Australia, Qatar, Saudi Arabia, Myanmar, etc. In the unlikely occasion if you’re looking for a product or brand, Click here.